-
Website
http://venturebeat.com/ -
Original page
http://deals.venturebeat.com/2007/11/27/cancer-drug-biotech-agensys-sells-to-astellas-for-387m-but-is-it-a-pig-in-a-poke/ -
Subscribe
All Comments -
Community
-
Top Commenters
-
ed hardy
515 comments · 1 points
-
Eric Eldon
349 comments · 13 points
-
edsion007
54 comments · 4 points
-
Haggie
94 comments · 4 points
-
MG Siegler
1126 comments · 30 points
-
-
Popular Threads
-
Speed test shocker: AT&T wins Gizmodo’s 12-city 3G megatest
4 hours ago · 3 comments
-
Does Avatar represent the future of movies? Maybe not
8 hours ago · 4 comments
-
Twitter is profitable, says BusinessWeek
10 hours ago · 3 comments
-
Game startups raised $600.5 million in 2009, down 36 percent
7 hours ago · 2 comments
-
Limelight goes interactive, buys ad agency EyeWonder
5 hours ago · 1 comment
-
Speed test shocker: AT&T wins Gizmodo’s 12-city 3G megatest
VentureBeat: Cancer-drug biotech Agensys sells to Astellas for $387M — but is it a pig in a poke?
There are no comments yet.